Location History:
- Naples, IT (2009)
- Napoli, IT (2012)
Company Filing History:
Years Active: 2009-2012
Title: Renata Piccoli: Innovator in Antibody Development
Introduction
Renata Piccoli is a notable inventor based in Napoli, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of human mini-antibodies for therapeutic applications. With a total of 2 patents, her work focuses on innovative solutions for cancer treatment.
Latest Patents
One of her latest patents is titled "Human mini-antibody cytotoxic for tumor cells which express the ERBB2 receptor." This invention refers to a fully human miniantibody (scFv), called Erbicin, which is specific for the receptor ErbB2 and exhibits pharmacological, particularly antitumor, activity. The miniantibody has been obtained from a larger phage display library (Griffin 1) through panning, which involves affinity selection on antigen carried out on live cells expressing various levels of ErbB2. The invention also encompasses the DNA and amino acid sequences of the antibody, the procedure for isolating it, and its therapeutic uses.
Career Highlights
Renata has worked with several companies in the biotechnology sector, including Biotechnol S.A. and Biotecnol S.A. Her experience in these organizations has contributed to her expertise in antibody development and therapeutic applications.
Collaborations
Throughout her career, Renata has collaborated with notable colleagues such as Giuseppe D'Alessio and Claudia De Lorenzo. These partnerships have enhanced her research and development efforts in the field of biotechnology.
Conclusion
Renata Piccoli is a pioneering inventor whose work in human mini-antibodies has the potential to revolutionize cancer treatment. Her innovative approaches and collaborations continue to make a significant impact in the biotechnology industry.